Teklalife sciences Investors · Transaction Sep 19, 2016 · Filed Sep 28, 2016 · $1,001 to $15,000
NEW YORK STOCK EXCHANGE, INC. · HQL
+4.13% · +$0.7200 · Vol 104.9K
Market closed · last close 4:00 PM ET · price as of 19:00:00 ET
HQL
abrdn Life Sciences Investors
N/A
$18.15
Follow $HQL
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $HQL by emailVeridion Score
Refresh
Score snapshot refresh in progress
Veridion Score History · 90D
Score not reportedVeridion does not publish a score-history trend for HQL until the ticker has a real scored snapshot. No trend is implied for this page.Review methodology
AI Analysis
SovereignWhy is HQL moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About abrdn Life Sciences Investors
N/AListed since
1992
Country
US
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$17.60
Day high
$18.18
Day low
$17.45
Previous close
$17.43
52W high
$22.67
-19.94% from high
52W low
$15.87
34% of range
Market cap
$551.9M
P/E
2.63×
EPS
$6.60
Beta
0.59
Shares out
30.4M
Volume
104.9K
0.80× rel vol
Avg volume
130.5K
VWAP
$17.88
Price history computed in-house
1W
+2.66%
1M
-8.29%
3M
-10.50%
1Y
+13.44%
YTD
+8.16%
SMA 50 $20.03 · below
SMA 200 $18.18 · below
52W position 34%
HQL overview
Related filings and maps
Financials
Company financial statements are not applicable for HQL.
Public disclosures
Congress activity in HQL
1 filers · 4 buys · 2 sells (0 labeled S (partial)) · Feb 21, 2014 to Sep 19, 2016 · House 6 / Senate 0
All available history · Latest 5 of 6 lines · Read 2026-10-10T10:37:38.502Z
Official filing ↗
Teklalife sciences Investors · Transaction Feb 12, 2016 · Filed Mar 3, 2016 · $1,001 to $15,000
Teklalife sciences Investors · Transaction Jan 13, 2016 · Filed Feb 8, 2016 · $1,001 to $15,000
Teklalife sciences Investors · Transaction Oct 15, 2015 · Filed Nov 2, 2015 · $1,001 to $15,000
Teklalife sciences Investors · Transaction Jul 14, 2015 · Filed Aug 13, 2015 · $1,001 to $15,000
Federal contracts
HQL contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for HQL in this window.
Lobbying spend
HQL lobbying filings, year to date.
Registered lobbying filings matched to abrdn Life Sciences Investors.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for HQL in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for HQL.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.